Plasma Membrane Blebbing Is Controlled by Subcellular Distribution of Vimentin Intermediate Filaments
Cells · 2024
DOI: 10.3390/cells13010105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Aleksandra S Chikina und 8 weiteren Autor:innen. Beteiligte Einrichtung: N.N. Blokhin National Medical Research Center of Oncology, 24 Kashirskoe Shosse, Moscow 115478, Russia. Hauptthemen laut MEDLINE: Intermediate Filaments. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Russian Science Foundation (RSF), National Institutes of Health.
Abstract (Originalsprache)
The formation of specific cellular protrusions, plasma membrane blebs, underlies the amoeboid mode of cell motility, which is characteristic for free-living amoebae and leukocytes, and can also be adopted by stem and tumor cells to bypass unfavorable migration conditions and thus facilitate their long-distance migration. Not all cells are equally prone to bleb formation. We have previously shown that membrane blebbing can be experimentally induced in a subset of HT1080 fibrosarcoma cells, whereas other cells in the same culture under the same conditions retain non-blebbing mesenchymal morphology. Here we show that this heterogeneity is associated with the distribution of vimentin intermediate filaments (VIFs). Using different approaches to alter the VIF organization, we show that blebbing activity is biased toward cell edges lacking abundant VIFs, whereas the VIF-rich regions of the cell periphery exhibit low blebbing activity. This pattern is observed both in interphase fibroblasts, with and without experimentally induced blebbing, and during mitosis-associated blebbing. Moreover, the downregulation of vimentin expression or displacement of VIFs away from the cell periphery promotes blebbing even in cells resistant to bleb-inducing treatments. Thus, we reveal a new important function of VIFs in cell physiology that involves the regulation of non-apoptotic blebbing essential for amoeboid cell migration and mitosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- N.N. Blokhin National Medical Research Center of Oncology, 24 Kashirskoe Shosse, Moscow 115478, Russia.
- Dynamics of Immune Responses Team, INSERM-U1223 Institut Pasteur, 25-28 Rue du Dr Roux, 75015 Paris, France.
- Department of Biology and A.N. Belozersky Institute of Physico-Chemical Biology, M.V. Lomonosov Moscow State University, 1 Leninskie Gory, Moscow 119992, Russia.
- Institute of Protein Research, Department of Cell Biology, Russian Academy of Sciences, Moscow 119988, Russia.
- Institut Curie, PSL Research University, INSERM U932, 26 rue d'Ulm, 75248 Paris, France.
- Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
ORCID-Profile: Aleksandra S Chikina, Igor I Kireev
Förderung
- NIGMS NIH HHS
- Russian Science Foundation (RSF)
- National Institutes of Health
- Lomonosov Moscow State University Development Program (PNR 5.13)
Zitieren
APA
Chikina, A. S., Zholudeva, A. O., Lomakina, M. E., Kireev, I. I., Dayal, A. A., Minin, A. A., Maurin, M., Svitkina, T. M., & Alexandrova, A. Y. (2024). Plasma Membrane Blebbing Is Controlled by Subcellular Distribution of Vimentin Intermediate Filaments. Cells. https://doi.org/10.3390/cells13010105
Vancouver
Chikina AS, Zholudeva AO, Lomakina ME, Kireev II, Dayal AA, Minin AA, et al. Plasma Membrane Blebbing Is Controlled by Subcellular Distribution of Vimentin Intermediate Filaments. Cells. 2024. doi:10.3390/cells13010105
BibTeX
@article{Chikina2024,
author = {Chikina, Aleksandra S and Zholudeva, Anna O and Lomakina, Maria E and Kireev, Igor I and Dayal, Alexander A and Minin, Alexander A and Maurin, Mathieu and Svitkina, Tatyana M and Alexandrova, Antonina Y},
title = {Plasma Membrane Blebbing Is Controlled by Subcellular Distribution of Vimentin Intermediate Filaments},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13010105}
}
EUVIMED